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Abstract
Background: An important issue in pediatric pharmacology is the determination of whether
medications affect cardiac rhythm parameters, in particular the QT interval, which is a surrogate
marker for the risk of adverse cardiac events and sudden death. To evaluate changes while on
medication, it is useful to have a comparison of age appropriate values while off medication. The
present meta-analysis provides baseline ECG values (i.e., off medication) from approximately 6000
children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
Methods: Subjects were aged 6–18 years and participated in global trials within the atomoxetine
registration program. Patients were administered a 12-lead ECG at study screening and cardiac
rhythm parameters were recorded. Baseline QT intervals were corrected for heart rate using 3
different methods: Bazett's, Fridericia's, and a population data-derived formula.
Results: ECG data were obtained from 5289 North American and 641 non-North American
children and adolescents. Means and percentiles are presented for each ECG measure and QTc
interval based on pubertal status as defined by age and sex. Prior treatment history with stimulants
and racial origin (Caucasian) were each associated with significantly longer mean QTc values.
Conclusion: Baseline ECG and QTc data from almost 6000 children and adolescents presenting
with ADHD are provided to contribute to the knowledge base regarding mean values for pediatric
cardiac parameters. Consistent with other studies of QT interval in children and adolescents,
Bazett correction formula appears to overestimate the prevalence of prolonged QTc in the
pediatric population.
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Background
The effect of medications on cardiac function, in particu-
lar the QT interval, has been an area of increasing focus in
pediatric pharmacology. The QT interval is a measure of
the period of depolarization and repolarization of the
ventricles. Patients with a congenital or acquired condi-
tion of prolonged QT intervals, known as Long QT Syn-
drome, have a high incidence of cardiac events, syncope,
and sudden death [1,2]. Prolonged QT intervals may be
associated with fatal cardiac arrhythmias, such as torsades
de pointes, and have therefore become a surrogate marker
for a potential increased risk of cardiac sudden death [3].
Determination of whether the QT interval is prolonged
can be made in reference to population norms. Because
ECGs of pediatric patients differ from those of adults in a
number of ways, specific normative data has to be estab-
lished for this population. In one of the earliest studies
with computerized ECG recordings, Davignon et al. [4]
provided ECG values from over 2000 infants and chil-
dren. Although this study is referenced frequently, the
ECG parameter graphs and tables are not readily accessi-
ble as they were not published within the original article.
Further, this dataset has been critiqued as being less appli-
cable now due to changes in computerized technology
and measurement standards as well as in patient popula-
tions (e.g., inclusion of non-whites, changes in mean val-
ues of height and weight) [5]. More recent population
studies in children have been conducted in several coun-
tries. Fukushige et al., [6] analyzed ECG data from 4655
children in Japan at first and seventh grades; thus, meas-
urements were taken only at 2 ages. Two smaller studies
have examined children and adolescents across ages; one
in the Netherlands (1912 subjects) [7] and one in Ger-
many (373 subjects) [8].
Interpretation of whether the QT interval is prolonged is
also dependent upon the method by which the interval
measurement is corrected for heart rate (QTc). Correction
is particularly important for pediatric patients because
heart rate changes substantially during childhood devel-
opment. At least 17 QT correction formulas have been
suggested in the literature, but there is no universally
accepted method [9]. Bazett's method is used most fre-
quently but often results in an over-estimate of QT pro-
longation at higher heart rates. Fridericia's method is
considered to be more appropriate at higher heart rates (as
would be seen in pediatric populations) but may slightly
underestimate cases of prolonged QT [10]. Others have
suggested a correction based on values derived from
repeated measurements of the population under study. In
the data-derived method, the correction factor is the
numeric value that results in a zero correlation between
RR interval and corrected QT interval values. One limita-
tion of the data-derived method is the feasibility of deter-
mination of multiple assessments with the same
population; however, Wernicke et al., have provided a
correction factor for the ADHD population based on anal-
ysis of repeated measures within 7 clinical trials [11].
The objective of the present meta-analysis is to provide
descriptive values for the QTc interval based on approxi-
mately 6000 children and adolescents who presented
with the neurodevelopmental condition attention-deficit/
hyperactivity disorder (ADHD) and were physically
healthy. ECG data were obtained as part of the global
development and registration program for atomoxetine,
which is a selective norepinephrine reuptake inhibitor
used for the treatment of ADHD. A second goal of this
study was to provide mean values based on different
methods of correction for the QT interval. We used
Bazett's method and the Fridericia method, which are the
most common. We also included values using the data-
derived formula for this specific population to illustrate
how values from this method compare to the traditional
formulas [11].
Methods
Subjects
Patients were children and adolescents aged 6 to 18 years
who were recruited by referrals and advertisements. The
studies included in the analyses were 20 clinical trials con-
ducted in outpatient academic and private research cent-
ers in the United States, Canada, Puerto Rico, Europe,
South Africa, Australia, and Israel. Subjects in this meta-
analysis were being evaluated for participation in ADHD
trials, but they were not excluded from the present study
dataset if they did not meet their clinical trial's inclusion
criteria. Subjects were diagnosed with ADHD as per the
investigators clinical judgment, and then had to meet a
minimum severity using the DSM-IV ADHD criteria. As
the data obtained for this analysis was gathered at initial
screen visits, subjects may or may not have met the criteria
for ADHD. Of the total sample of 5930 entered subjects,
88% were eventually enrolled into their particular study.
If a patient was currently on treatment for their ADHD, in
order to enter the atomoxetine clinical trial program, they
would need to have their baseline measurements taken
while off all medication. Therefore, prior to screening and
ECG recording, patients would have undergone a washout
period equal to 5 half lives of their ongoing treatment.
Each study was conducted in accordance with the princi-
ples of the Declaration of Helsinki [12] and country spe-
cific ethical review guidelines. Each site's ethical review
board independently reviewed and approved each study,
and written informed consent to participate was obtained
from the parent or guardian of each patient, as well as
written assent from each patient.Child and Adolescent Psychiatry and Mental Health 2007, 1:11 http://www.capmh.com/content/1/1/11
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Procedures
Within the clinical trials, all patients underwent a compre-
hensive baseline evaluation of health status that included
laboratory examination of blood and urine chemistries;
clinical examination of vital signs, height, and weight; and
a 12-lead electrocardiogram. The present analysis
included ECG parameters collected from this baseline
assessment prior to being assigned to treatment.
The ECG data were recorded at different investigator cent-
ers, but sent via direct transmission to a central ECG ven-
dor, which used the Marquette 12SL ECG analysis
program. The QT interval was measured in 3 leads on each
12-lead ECG: II, aVF, and V5. If any or all of the 3 leads
were unmeasurable, alternate leads were used based on
the pre-established sequence of: V3, V4, V6, I, III, AVL, V1,
and V2. If sinus arrhythmia was present, the QT interval
was the average of 5 different beats; in order to sample 5
different R-R intervals, QT was measured in II, aVF, V3,
V4, and V5. If any or all of these 5 leads were unmeasura-
ble, alternate leads were measured based upon the pre-
established sequence of: V6, I, III, aVF, V1, and V2.
Within a trial, each ECG was read by the same pediatric
cardiologist although cardiologists differed among the tri-
als. For the cardiologist readings, the offset of a new QT
interval was defined as the intersection of the line drawn
along the downslopes of the T wave and the isoelectric
line. U waves were ignored, but if a U wave or abnormal T
wave obscured the offset of the T wave, then the offset of
the QT interval was defined as the intersection of the tan-
gent to the midpoint of the downslope of the T wave and
the isoelectric baseline. Cardiologists made comments
using the Marquette standard codes, which were then
entered into the global safety database.
Statistical methods
ECG parameters (heart rate; RR, PR, QRS, and QT inter-
vals) and baseline characteristics were summarized for all
entered patients. Subjects were classified as Caucasian or
non-Caucasian, which included patients who identified
themselves as being African, Hispanic, East Asian, or West
Asian (Indian) origin. Between-group comparisons on
continuous variables were assessed using an analysis of
variance (ANOVA) with a term for the corresponding sub-
group. All tests used a 2-sided significance level of .05.
As QT interval has an inverse relationship with heart rate,
the measured QT intervals are usually corrected for heart
rate in order to determine wether they are prolonged rela-
tive to baseline. Bazett and Fridercia are the most widely
used methods of correction [11]. In addition a data-
derived approach of the population under study, based on
linear regression techniques may be most accurate [11].
We therefore used all 3 correction methods for the QT
interval. In the Bazett method, the QT interval was divided
by the square root of the R-R interval (defined as the
length of the entire cardiac cycle). In the Fridericia for-
mula, the QT interval was divided by the cube root of the
R-R interval [10]. For the data-derived correction factor,
we used the value that was determined in the Wernicke et
al. study [11] by repeated ECG assessments of 2288 chil-
dren and adolescents with ADHD. This data-derived fac-
tor of 0.38 falls between correction factors associated with
the Bazett (0.50) and Fridericia (0.33) formulas.
Moss and Robinson [13], recommended that a QTc inter-
val >460 ms be considered prolonged for women and
children, as this value represents the top 1% of current,
normal QTc distribution. Similarly, although the FDA
acknowledges that no absolute agreement exists on the
upper limit values for the QTc interval, in clinical trials, a
QTc >500 ms has been identified as a concern [14]. There-
fore, the proportions of patients with QTc >460 ms or QTc
>500 ms were specifically identified and summarized for
the entire sample. Mean QTc intervals using the different
correction methods were also examined by pubertal
grouping, which was defined by sex and age rather than by
a medical assessment of whether the child had actually
entered puberty. The prepubertal subjects consisted of
females ≤ 8 years old and males ≤ 9 years old; the pubertal
group was females between 8 and 13 years and males
between 9 and 14 years; and the postpubertal group was
females > 13 years and males > 14 years.
Results
The entire sample comprised 5930 children and adoles-
cents (Table 1); 5289 (89.2%) were from North America
(US, Canada, Puerto Rico) and 641 (10.8%) were from
non-North American countries. The non-North American
group had a greater proportion of males and Caucasian
patients than the North American group, although both
groups demonstrated greater frequencies of males than
females, as expected for the ADHD population. The mean
age of the sample was approximately 10.7 years. Approxi-
mately 61.5% of the sample had a history of prior expo-
sure to stimulant treatment.
Baseline mean values for ECG parameters by pubertal 
group
In Tables 2, 3, 4, the mean values, standard deviations,
and percentile scores for the ECG parameters are dis-
played by pubertal status. As developmentally expected,
mean heart rate values decreased with age. Figure 1 shows
the split diagrams of QTc by pubertal status and gender;
the most consistent finding was in the post-pubertal age
group, in which postpubertal males had significantly
shorter QTc intervals than postpubertal females for each
correction method (402.8 msec for postpubertal males vsChild and Adolescent Psychiatry and Mental Health 2007, 1:11 http://www.capmh.com/content/1/1/11
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409.5 for postpubertal females, data-derived formula for
QT correction, P ≤ .001, Figure 1).
Baseline ECG mean values for subgroup populations
In addition to pubertal status, we also explored differ-
ences in QTc values based on prior treatment history.
Patients who had a history of stimulant exposure had a
small, but significantly greater heart rate compared with
patients who had not received stimulants (77.5 bpm in
treatment-naïve patients vs 78.3 bpm in stimulant-experi-
enced patients, P ≤ .05). The mean QTc values of the stim-
ulant-experienced were slightly higher across the 3
correction methods compared with the stimulant-naive (P
≤ .001, all comparisons; Table 5).
Baseline values also differed significantly based on racial
origin. Comparisons between Caucasians and non-Cauca-
sians children and adolescent showed that Caucasian sub-
jects had significantly higher mean values in most ECG
parameter except PR and QT intervals (Table 6). For each
of the 3 correction methods, Caucasians also had signifi-
cantly higher mean QTc values than did non-Caucasian
subjects (P ≤ .001, all comparisons).
Frequencies of prolonged QTc intervals
The frequency of prolonged QTc was determined using
the Moss and Robinson criteria of > 460 ms and the regu-
latory criteria of > 500 ms. With the criteria of a QTc >460
ms, the prevalence of QTc prolongation was 1.53% (91/
5930) for the Bazett formula, 0.30% (18/5930) for the
data-derived formula, and 0.27% (16/5930) for Frideri-
cia's formula. With the criteria of QTc interval > 500 ms,
the prevalence of prolongation was 0.12% (7/5930) for
the Bazett formula, 0.12% (7/5930) for the data-derived
formula, and 0.10 (6/5930) for Fridericia's formula.
Table 1: Demographics of Children and Adolescents Presenting with ADHD Across Clinical Trials by Region
North American (n = 5289) Non-North American (n = 641)
Country of origin: (n,%)
United States 5046 (95.4)
Canada 135 (2.6)
Puerto Rico 108 (2.0)
European 490 (76.4)
South Africa 71 (11.1)
Australia 47 (7.3)
Israel 33 (5.1)
Sex: n (%) Male 4013 (76) 572 (89)
Age: Mean years, SD 10.7 (2.6) 10.2 (2.3)
*Weight (kg): Mean, SD 40.5 (15.1) 37.4 (12.7)
Percentile (Mean, SD) 60.9 (29.2) 58.9 (28.9)
*Height (cm): Mean, SD 142.4 (16.8) 142.0 (14.5)
Percentile (Mean, SD) 51.4 (29.2) 57.8 (28.7)
Body Mass Index: Mean, SD 19.2 (4.0) 18.1 (3.4)
% Caucasian n (%) 4008 (76) 619 (97)
* Sample sizes for weight, height, and body mass were slightly lower
Table 2: Mean and Percentiles of ECG Cardiac Measures Among Pre-pubertal Children
ECG Variable Mean (sd) 1st %ile 5th %ile Median 95th %ile 99th %ile
Heart Rate (bpm) 83.0 (12.1) 59.0 65.0 82.0 104 114.0
RR Interval (ms) 738.5 (107.8) 526.3 576.9 731.7 923.1 1040.0
PR Interval (ms) 132.8 (17.3) 100.0 108.0 130.0 162.0 180.0
QRS Interval (ms) 80.0 (9.0) 64.0 70.0 80.0 96.0 102.0
QT Interval (ms) 354.7 (24.3) 300.0 318.0 352.0 396.0 416.0
QTc Bazett (ms) 414.0 (19.6) 367.0 383.0 414.0 443.0 460.0
QTc Data-derived (ms) 399 (17.3) 357.4 372.0 398.7 424.1 439.6
QTc Fridericia (ms) 393.2 (17.1) 353.3 366.3 392.9 419.0 433.0
Note: Pre-pubertal group (N = 1537) defined as females whose age was ≤ 8 years (n = 224) and males whose age was ≤ 9 years (n = 1313)-
Abbreviations: RR, Duration of ventricular cardiac cycle (an indication of ventricular rate); PR, Time from the onset of atrial depolarization (P wave) 
to onset of ventricular depolarization (QRS complex); QTcb, Bazett's method for QT interval correction; QTcd, Data-derived corrected method 
for QT interval correction; QTcf, Fridericia's method for QT interval correction.Child and Adolescent Psychiatry and Mental Health 2007, 1:11 http://www.capmh.com/content/1/1/11
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Seven subjects had a QTc interval greater than 500 msec
based on any 1 of the 3 correction formulas. For these
cases, clinical information that was available from the
screening visit was reviewed. The 7 patients had each been
previously asymptomatic with no recorded history of syn-
cope; 1 had a history of a heart murmur as an infant that
was undetected upon physical examination during the
screening; and 1 had sinus bradycardia and right axis devi-
ation in addition to prolonged QT. The 7 subjects (6
males, 1 female) were pubertal age or younger (6 to 13
years) and did not vary from their pediatric norms in
height, weight, BMI, or blood pressure; however, heart
rate varied considerably. Two subjects had an elevated
baseline heart rate: 150 bpm (age 11.1 years) and 103
bpm (age 7.2 years) compared with their age norms. QTc
intervals greater than 500 msec was an exclusion criterion
for the atomoxetine clinical trials; thus, none of these
patients entered the clinical studies and were referred back
to their family pediatrician for further medical care and
follow-up as appropriate.
Discussion
Understanding the distribution of cardiac parameters in
children and adolescents is essential for the implementa-
tion of pediatric pharmacology. Indeed, considerable
interest in the cardiovascular risks associated with ADHD
medications exists from a regulatory perspective because
of the high prevalence of ADHD and the widespread use
of sympathomimetic agents that may increase blood pres-
sure, heart rate, and cardiac rhythm parameters [15]. To
ascertain changes in ECG parameters while on ADHD
medication, it is important to have an understanding of
the ECG values while off medication across the age range.
Nonetheless, the determination of whether the QT inter-
val is prolonged by a medication can be equivocal. For
example, one regulatory definition of prolongation is a
within-patient increase of 30 msec following initiation of
a medication. However, in a meta-analysis of atomoxetine
trials, 8.6% of patients who were taking placebo had at
least a 30 msec increase [11]. Therefore, sole reliance on
within-patient change may result in a high number of
false positives, which suggests an alternative strategy that
combines population norms based on sex and age as well
as within-patient changes.
Age, sex, and racial origin were each factors that impacted
mean baseline ECG values. Males in the post-pubertal age
category were found to have significantly shorter QTc
Table 4: Mean and Percentiles of ECG Cardiac Measures Among Post-Pubertal Children
ECG Variable Mean (sd) 1st %ile 5th %ile Median 95th %ile 99th %ile
Heart Rate (bpm) 70.8 (11.4) 48.0 52.0 70.0 91.0 102.0
RR Interval 870.3 (144.3) 588.2 659.3 857.1 1153.8 1250.0
PR Interval (ms) 140.8 (18.9) 104.0 116.0 140.0 176.0 192.0
QRS Interval (ms) 87.8 (9.9) 70.0 72.0 88.0 104.0 112.0
QT Interval (ms) 382.9 (29.0) 328.0 340.0 380.0 432.0 470.0
QTc Bazett (ms) 412.2 (20.7) 350.0 376.0 413.0 444.0 457.0
QTc Data-derived (ms) 405.0 (18.5) 357.2 371.6 406.5 433.0 447.5
QTc Fridericia (ms) 402.1 (18.5) 354.5 371.1 402.6 430.9 446.5
Note: Post-Pubertal group (N = 737) defined as females whose age was >13 yrs (n = 240) and males whose age was > 14 yrs (n = 497)
Abbreviations: RR, Duration of ventricular cardiac cycle (an indication of ventricular rate); PR, Time from the onset of atrial depolarization (P wave) 
to onset of ventricular depolarization (QRS complex); QTcb, Bazett's method for QT interval correction; QTcd, Data-derived corrected method 
for QT interval correction; QTf, Fridericia's method for QT interval correction.
Table 3: Mean and Percentiles of ECG Cardiac Measures Among Pubertal Children
ECG Variable Mean (sd) 1st %ile 5th %ile Median 95th %ile 99th %ile
Heart Rate (bpm) 77.4 (11.8) 54.0 60.0 76.0 98.0 109.0
RR Interval 792.9 (121.1) 555.6 612.2 780.0 1000.0 1132.0
PR Interval (ms) 136.8 (18.5) 100.0 112.0 136.0 170.0 109.0
QRS Interval (ms) 83.0 (9.1) 68.0 70.0 80.0 96.0 106.0
QT Interval (ms) 368.8 (27.0.) 310.0 330.0 368.0 412.0 440.0
QTc Bazett (ms) 415.6 (21.3) 362.0 381.0 416.0 448.0 468.0
QTc Data-derived (ms) 403.9 (19.1) 357.0 373.3 404.0 433.1 450.1
QTc Fridericia (ms) 399.4 (19.0) 354.5 369.4 399.6 429.0 443.9
Note: Pubertal group (N = 3656) defined as females whose age was > 8 and ≤ 13 years (n = 881) and males whose age was > 9 and 
≤ 14 years (n = 2775).
Abbreviations: RR, Duration of ventricular cardiac cycle (an indication of ventricular rate); PR, Time from the onset of atrial depolarization (P 
wave) to onset of ventricular depolarization (QRS complex); QTcb, Bazett's method for QT interval correction; QTcd, Data-derived corrected 
method for QT interval correction; QTf, Fridericia's method for QT interval correction.Child and Adolescent Psychiatry and Mental Health 2007, 1:11 http://www.capmh.com/content/1/1/11
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intervals than postpubertal females (402.8 msec vs. 409.5
msec, data-derived formula). Other studies also have
shown that onset of sex differences in corrected QT occurs
with puberty, but the reason for this difference and its
clinical relevance is unclear [9]. With regard to racial ori-
gin, Caucasian children demonstrated faster heart rate,
with correspondingly shorter ECG mean values, as well as
slightly longer QTc intervals than did children and adoles-
cents from other origins. This finding reflects genetic het-
erogeneity that may exist in physiology across ethnic
groups [16].
There are a number of strengths and limitations of the
meta-analysis. The considerable size and heterogeneity of
the sample provides information that is not captured by
current normative values in healthy children. Further, it
represents the first report of ECG parameters from such a
large sample of children who have a particular clinical
condition, and the subgroup of females (N = 1345) is
larger than previously reported female sample sizes from
other studies. An additional strength of the study was the
inclusion of 3 correction methods to allow for compari-
son of changes across age and sex. Mean values using the
data-derived method were similar to those values
observed with the Fridericia method. The prevalence rate
when using the Bazett method and Moss and Robinson
criteria were substantially higher (approximately 5-fold),
and thus this formula may overestimate the true preva-
lence of prolonged QTc. Therefore, clinically, when a pop-
ulation derived correction factor may not be available, the
optimum correction method for children would be the
Fridercia method [17].
This meta-analysis also has several limitations. First, chil-
dren were not formally assessed for their pubertal status,
and the definitions for pubertal grouping in this meta-
analysis were based on age rather than clinical examina-
tion. Another limitation is that the ECGs were computer-
ized and were read by different cardiologists across trials.
Computer-based methods have been criticized as demon-
strating less sensitivity in detecting prolonged QT intervals
[18]. The present study may underestimate or overesti-
mate baseline prevalence rates, but these ECG assessments
were measured using computer technology that is more
contemporary than the methods used for currently refer-
enced norms, such as those presented by Davignon et al.
[4].
In evaluating this dataset, several characteristics regarding
the subject population need to be considered. First, chil-
dren under 6 years of age were excluded, which precludes
this dataset as a population norm for all children. Simi-
Table 6: Mean Values for ECG Parameters for Caucasians and Non-Caucasians
ECG Variable Caucasian (n = 4627) Mean (SD) Non-Caucasian (n = 1303) Mean (SD) P value
Heart Rate (bpm) 78.3 (12.5) 76.8 (11.7) ***
RR Interval (ms) 785.2 (127.8) 799.6 (123.4) ***
PR Interval (ms) 135.3 (18.2) 139.7 (18.8) ***
QRS Interval (ms) 83.5 (9.4) 80.8 (9.0) ***
QT Interval (ms) 366.8 (28.2) 367.2 (27.0)
QTc
Bazett (ms) 415.5 (20.8) 412.2 (20.8) ***
Data-derived (ms) 403.3 (18.7) 400.9 (18.7) ***
Fridericia (ms) 398.5 (18.7) 396.6 (18.6) ***
***P ≤ .001
Table 5: Mean Values for ECG Parameters for Children and Adolescents with or without History of Stimulant Treatment
ECG Variable Stimulant Naive (n = 2239) Mean (SD) Stimulant Experienced (n = 3572) Mean (SD) P value
Heart Rate (bpm) 77.5 (11.7) 78.3 (12.7) *
RR Interval (ms) 791.3 (121.4) 786.6 (130.5)
PR Interval (ms) 136.6 (18.7) 136.1 (18.3)
QRS Interval (ms) 82.0 (9.0) 83.4 (9.6) ***
QT Interval (ms) 366.2 (26.2) 367.4 (29.0)
QTc
Bazett (ms) 413.1 (20.5) 415.9 (21.1) ***
Data-derived (ms) 401.4 (18.1) 403.7 (19.0) ***
Fridericia (ms) 396.8 (18.0) 399.0 (19.1) ***
* P ≤ .05, ***P ≤ .001Child and Adolescent Psychiatry and Mental Health 2007, 1:11 http://www.capmh.com/content/1/1/11
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larly, the population assessed in this study was predomi-
nantly male. Although this could be considered a
weakness of the analysis, it is reflective of the higher male
incidence within the ADHD population. In addition,
given the prevalence of ADHD (3 to 5%) [19], it is one of
the most common conditions involved in pediatric phar-
macology and thus of considerable public health impor-
tance [20]. A final consideration is that although these
children and adolescents were overall physically healthy,
the majority met criteria for ADHD. Psychopathology
could influence cardiac parameters via changes in auto-
nomic tone although ADHD has not been associated with
increased stress responsivity [21].
As a representative sample of children and adolescents
with ADHD, the values from this meta-analysis can be uti-
lized in the context of clinical decision making. With
increasing recognition that prolonging the QT interval
may be one of a number of risk factors associated with
serious adverse events, medications are being scrutinized
for their effects on cardiac parameters. In recent years, 9
medications have been withdrawn or have received the
cautionary "black box warning" by regulatory agencies
due to concerns about cardiac effects [22]. For the popu-
lation disease under study, ADHD, tricyclic antidepres-
sants are an off-label treatment intervention that has been
questioned for adverse cardiac events in children [23]. In
the present sample, prior stimulant history was associated
with small, but significantly greater mean QTc values,
although the clinical relevance of this finding is undeter-
mined. The baseline values in this paper serve as useful
reference for ADHD specialists and may assist clinical
decision making with regard to determination of rhythm
abnormality.
In summary, the present study provides important base-
line descriptions of the ECG and QT intervals from chil-
dren and adolescents across a number of geographical
regions. This considerable dataset can certainly be gener-
alizable to a population of children with ADHD, however,
it may not be entirely generalizable to a non-ADHD,
healthy pediatric population. Given that ADHD is the
most common neurodevelopmental disorder in child-
hood, these baseline ECG measures are of particular
value, and perhaps should be the standards for compari-
sons with subsequent ADHD populations. In addition, we
believe that this meta-analysis serves as a useful example
of how large research databases can be mined creatively to
provide clinically relevant and valuable information.
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Mean QTc intervals based on 3 correction methods by age  and sex for children and adolescents presenting with ADHD Figure 1
Mean QTc intervals based on 3 correction methods by age 
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